About inHEART
inHEART is a company based in Pessac (France) founded in 2017 by Jean Marc Peyrat, Pierre Jais, and Hubert Cochet. inHEART has raised $15.16 million across 2 funding rounds from investors including NACO, Vesalius Biocapital IV and Elaia. inHEART offers products and services including Digital Twin of the Heart and 3D Imaging Platform. inHEART operates in a competitive market with competitors including eCential Robotics, Biomodex, SentiAR, LensAR and Enhatch, among others.
- Headquarter Pessac, France
- Founders Jean Marc Peyrat, Pierre Jais, Hubert Cochet
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.16 M (USD)
in 2 rounds
-
Latest Funding Round
$11 M (USD), Series B
May 06, 2024
-
Investors
NACO
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of inHEART
inHEART offers a comprehensive portfolio of products and services, including Digital Twin of the Heart and 3D Imaging Platform.
AI tool for 3D heart modeling from images for ablation procedures.
Platform integrating with mapping systems to enhance cardiac treatments.
People of inHEART
Unlock access to complete
Unlock access to complete
Funding Insights of inHEART
inHEART has successfully raised a total of $15.16M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $11 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in inHEART
inHEART has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include NACO, Vesalius Biocapital IV and Elaia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A European life sciences venture capital investor is operated.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on early-stage investments
|
Locked | Locked | Locked | |
|
A venture capital fund focused on co-investing in startups.
|
Locked | Locked | Locked |
Investor details for inHEART
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by inHEART
Investment portfolio details for inHEART
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - inHEART
Detailed financials for inHEART
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inheart Comparisons
Peer comparison for inHEART
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of inHEART
inHEART operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eCential Robotics, Biomodex, SentiAR, LensAR and Enhatch, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
3D printed surgical simulators for medical education and patient-specific preoperative planning
|
|
| Locked | Locked | Locked |
A 3D visualization platform is offered for interventional cardiac procedures.
|
|
| Locked | Locked | Locked |
Laser and 3D imaging technology for cataract surgery is developed.
|
|
| Locked | Locked | Locked |
Provider of mobile enterprise apps for Salesforce
|
Detailed competitors of inHEART
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inheart
Complete news archive for inHEART
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about inHEART
inHEART was founded in 2017 and raised its 1st funding round 3 years after it was founded.
inHEART is headquartered in Pessac, France. It is registered at Pessac, Gironde, France.
Todor Jeliaskov is the current CEO of inHEART.
inHEART is a funded company, having raised a total of $15.16M across 2 funding rounds to date.
inHEART was founded in 2017 in Pessac, France, within the medical technology sector focused on cardiology. Software is provided for creating 3D models of cardiac anatomy, supporting educational tools and therapeutic strategies for healthcare providers. Features include segmentation algorithms for tissue details, structural analysis, and integration with electroanatomic mapping systems to aid clinical operations.
inHEART's top competitors include eCential Robotics, LensAR and SurgAR.
inHEART offers Digital Twin of the Heart and 3D Imaging Platform.
inHEART has 8 investors. Key investors include NACO, Vesalius Biocapital IV, Elaia, SAGANA, and Sofia Angels Ventures.